FULC
Fulcrum Therapeutics, Inc. · Healthcare
Director Robert J Gould sold $178K of Fulcrum Therapeutics, Inc.
Sold$178,089
$11.87Price
15,000Shares
−3%Stake
What FULC did after the filing
- The stock from Tue, Jan 6 close, $9.99
- +17.4%
- S&P 500, same days
- −1.1%
Measured over 30 trading days, to the Feb 19 close.
Traded Fri, Jan 2. Filed Tue, Jan 6, 11:30 AM ET, during the session. Returns use the Jan 6 close and the Feb 19 close. Not investment advice.